Comparison · NCT02079025-sae
LR-TRUS vs UHR-TRUS: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. LR-TRUS vs UHR-TRUS: serious adverse events. Trial comparisons, record NCT02079025-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02079025-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.00358 | 0.00122 | 0.0105 | wilson | |
| Risk in group 2 | 0.00358 | 0.00122 | 0.0105 | wilson | |
| Risk difference, group 1 minus group 2 | -0.00000854 | -0.0073 | 0.00727 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.998 | 0.202 | 4.93 | log | |
| Odds ratio, group 1 over group 2 | 0.998 | 0.201 | 4.96 | log | |
| Number needed to treat, for one fewer participant with a serious adverse event on LR-TRUS than on UHR-TRUS | 117,000 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | LR-TRUS | Low-resolution transrectal ultrasound guided prostate biopsy (standard of care)~Standard ultrasound guided prostate biopsy: Ultrasound guided prostate biopsy using standard of care ultrasound system | 3 | 839 | EG000 |
| Group 2 | UHR-TRUS | Ultra-high resolution transrectal ultrasound guided prostate biopsy~High-resolution ultrasound guided prostate biopsy: Ultrasound guided prostate biopsy using ultra-high resolution ultrasound system | 3 | 837 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
Source ClinicalTrials.gov
Trial
- Title
- Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer
- NCT number
- NCT02079025
- Phases
- NA
- Conditions
- Prostatic Neoplasms, Prostate Cancer, Cancer of the Prostate
- Interventions
- High-resolution ultrasound guided prostate biopsy, Standard ultrasound guided prostate biopsy
- Lead sponsor
- Exact Imaging
- Results first posted
- 2019-01-08
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02079025?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02079025-sae